Addex Therapeutics Ltd Statistics Share Statistics Addex Therapeutics Ltd has 819.55K
shares outstanding. The number of shares has increased by -42.08%
in one year.
Shares Outstanding 819.55K Shares Change (YoY) -42.08% Shares Change (QoQ) 0% Owned by Institutions (%) 6.21% Shares Floating 819.31K Failed to Deliver (FTD) Shares 3,261 FTD / Avg. Volume 15%
Short Selling Information The latest short interest is 45.95K, so 4.3% of the outstanding
shares have been sold short.
Short Interest 45.95K Short % of Shares Out 4.3% Short % of Float 5.49% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is 0.74 and the forward
PE ratio is -1.73.
Addex Therapeutics Ltd's PEG ratio is
0.
PE Ratio 0.74 Forward PE -1.73 PS Ratio 12.67 Forward PS 4.6 PB Ratio 0.54 P/FCF Ratio -0.97 PEG Ratio 0
Financial Ratio History Enterprise Valuation Addex Therapeutics Ltd has an Enterprise Value (EV) of 1.9M.
EV / Sales 4.62 EV / EBITDA -0.41 EV / EBIT -0.35 EV / FCF -0.35
Financial Position The company has a current ratio of 4.42,
with a Debt / Equity ratio of 0.
Current Ratio 4.42 Quick Ratio 4.42 Debt / Equity 0 Debt / EBITDA -0.01 Debt / FCF -0.01 Interest Coverage -776.78
Financial Efficiency Return on Equity is 72.91% and Return on Invested Capital is -27.88%.
Return on Equity 72.91% Return on Assets 66.08% Return on Invested Capital -27.88% Revenue Per Employee $205.02K Profits Per Employee $3.53M Employee Count 2 Asset Turnover 0.04 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -2.66% in the
last 52 weeks. The beta is 1.4, so Addex Therapeutics Ltd's
price volatility has been higher than the market average.
Beta 1.4 52-Week Price Change -2.66% 50-Day Moving Average 8.55 200-Day Moving Average 8.13 Relative Strength Index (RSI) 53.98 Average Volume (20 Days) 21,744
Income Statement In the last 12 months, Addex Therapeutics Ltd had revenue of 410.04K
and earned 7.06M
in profits. Earnings per share was 8.4.
Revenue 410.04K Gross Profit -444.26K Operating Income -2.76M Net Income 7.06M EBITDA -4.65M EBIT -4.91M Earnings Per Share (EPS) 8.4
Full Income Statement Balance Sheet The company has 3.34M in cash and 41.99K in
debt, giving a net cash position of 3.3M.
Cash & Cash Equivalents 3.34M Total Debt 41.99K Net Cash 3.3M Retained Earnings -353.36M Total Assets 9.48M Working Capital 2.14M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -5.37M
and capital expenditures -1.27K, giving a free cash flow of -5.37M.
Operating Cash Flow -5.37M Capital Expenditures -1.27K Free Cash Flow -5.37M FCF Per Share -6.57
Full Cash Flow Statement Margins Gross margin is -108.35%, with operating and profit margins of -671.94% and 1720.75%.
Gross Margin -108.35% Operating Margin -671.94% Pretax Margin -1197.28% Profit Margin 1720.75% EBITDA Margin -1132.98% EBIT Margin -671.94% FCF Margin -1310.8%
Dividends & Yields ADXN does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield 135.81% FCF Yield -103.46%
Dividend Details Analyst Forecast The average price target for ADXN is $30,
which is 227.9% higher than the current price. The consensus rating is "Buy".
Price Target $30 Price Target Difference 227.9% Analyst Consensus Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number 0.4 Graham Upside -95.63%
Stock Splits The last stock split was on Oct 23, 2023. It was a
backward
split with a ratio of 1:20.
Last Split Date Oct 23, 2023 Split Type backward Split Ratio 1:20
Scores Altman Z-Score -50.31 Piotroski F-Score 3
